🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for psoriasis

Molecular Inflammation Board at the Center for Personalized Medicine NCT07132333n/a1 site📍 Tübingen University Hospital Tuebingen · Tests: Biologic Agent Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER) NCT07611747Phase 417 sites📍 Alicante📍 Elche📍 Orihuela Instituto de Investigación Marqués de Valdecilla · Tests: Carotid Ultrasound, High-intensity lipid-lowering therapy, Standard care according to ESC 2021 guidelines Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor NCT07166315n/a1 site📍 Bath Adelphi Real World · Tests: observational study Study of S-4321 in Participants With an Autoimmune or Immune-mediated Disease NCT07455578Phase 12 sites📍 Charlestown📍 Birtinya Seismic Therapeutic AU Pty Ltd · Tests: S-4321 A Study of Tildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO) NCT06029257n/a1 site📍 Graz Almirall, S.A. · Tests: Tildrakizumab The Effect of Anti-IL17 on Airway Hyperresponsiveness and Resistance NCT06224634n/a1 site📍 Hvidovre Copenhagen University Hospital, Hvidovre Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications NCT04846959n/a2 sites📍 Morrisville📍 Wilmington AbbVie · Tests: Risankizumab, Comparator Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis NCT07039110n/a84 sites📍 Calgary📍 Edmonton📍 Winnipeg AbbVie Evaluate the Safety and Pharmacokinetics/Pharmacodynamics of HS-20118 NCT06846710Phase 19 sites📍 Anaheim📍 Miami Lakes📍 Pompano Beach Jiangsu Hansoh Pharmaceutical Co., Ltd. · Tests: HS-20118, HS-20118 placebo Effect of Addition of Pyramidal Exercise to Intermittent Fasting on Dryness of Eye in Pre-diabetic Psoriasis Patients NCT06893913NA1 site📍 Giza Cairo University · Tests: pyramidal training plus intermittent fasting, intermittent fasting Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis NCT03361215n/a1 site📍 Kiel University Hospital Schleswig-Holstein · Tests: Biosampling for molecular analysis Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry NCT02418442n/a82 sites📍 Birmingham📍 Phoenix📍 Los Angeles Duke University Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis NCT04036188EARLY Phase 11 site📍 Fairborn Wright State University · Tests: Triamcinolone, Vitamin D3, Placebo Taltz in Combination With Enstilar for Psoriasis NCT04372277Phase 41 site📍 East Windsor Psoriasis Treatment Center of Central New Jersey · Tests: Enstilar Phase II Clinical Trial of SHR-1139 Injection in Patients With Psoriasis NCT07719530Phase 21 site📍 Guangzhou Guangdong Hengrui Pharmaceutical Co., Ltd · Tests: The SHR-1139 injection, placebo Serum Substance P, Neuropathic Pain, and Central Sensitization Across Treatment Groups in Chronic Plaque Psoriasis NCT07844772n/a1 site📍 Istanbul Istanbul Training and Research Hospital · Tests: IL-17 Inhibitor Therapy, Conventional Systemic Therapy Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases NCT06599411n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Sampling, Sampling An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis NCT06764693n/a132 sites📍 Quilmes📍 San Isidro📍 Río Cuarto AbbVie Comparison Between Oral Methotrexate and Tofacitinib in Chronic Plaque Psoriasis NCT07261306EARLY Phase 11 site📍 Lahore Lahore General Hospital · Tests: Methotrexate, Tofacitinib Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis NCT07029516Phase 31 site📍 Milan Wooshin Labottach Co., Ltd. · Tests: Cosmetic patch containing urea applicated daily for 3 months, Placebo patch application Deployment o the Multidisciplinary Prospective Cohort Imminent NCT04334031NA1 site📍 Lille University Hospital, Lille · Tests: Biobanking with genetic analysis, SF-12 questionnaire Novel Skin Barrier Product Versus Petrolatum for Skin Barrier Dysfunction NCT07183423NA1 site📍 Makati City Makati Medical Center · Tests: Novel barrier repair topical product, Petrolatum A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis NCT07471048NA1 site📍 Englewood Sirt3 LLC · Tests: Oral supplement containing 200mg Magnolia officinalis bark extract, Placebo A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab NCT06100744Phase 334 sites📍 Little Rock📍 Washington D.C.📍 Hollywood AbbVie · Tests: Adalimumab, Risankizumab Skin Microbial Ecology in Atopic Dermatitis NCT04170244n/a1 site📍 Rochester University of Rochester · Tests: AD subject visit sampling procedures, PS subject visit sampling procedures, Healthy control visit sampling procedures A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis NCT06807424Phase 3236 sites📍 Glendale📍 Mesa📍 Jonesboro Janssen Research & Development, LLC · Tests: Icotrokinra, Placebo AYLo - AutoimmunitY and Loss of y NCT06696027n/a1 site📍 Bonn University of Bonn · Tests: Single nucleotide polymorphisms (SNP), 3'mRNA sequencing, Enzyme-linked immunosorbent assay (ELISA) and Legendplex… Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project NCT02103361n/a1 site📍 La Jolla University of California, San Diego · Tests: Ustekinumab, Guselkumab A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis NCT07326813Phase 31 site📍 Shanghai InventisBio Co., Ltd · Tests: D-2570 Tablet, BMS-986165 Tablet, Placebo Genetic Variation in TRAF3IP2 (rs13190932) NCT07086924NA1 site📍 Qina South Valley University · Tests: Methotrexate
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy